🔴 Painreform is trading 7.15% down with no identified company-specific explanation

Painreform is trading at $0.72, down 7.15%, with no new company-specific announcement identified to explain the October 29 move.

• The latest identified company update, dated October 23, covered cash, a planned Phase 2 trial, and GridFeed’s AI data-center opportunity.
• Broader market weakness may be a contributor: the Nasdaq Composite was down 1.30%, exceeding the 0.5% threshold in the same direction. Available information does not establish that the market decline caused Painreform’s move.